1

Diabetes Devices Market (By Product Types: Monitoring Devices, Treatment Devices; By End User: Diagnostic Centers, Hospitals, Home Care, Ambulatory Surgery Centers; By Distribution Channels: Hospitals Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Diabetes Devices
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Diabetes Devices Market By Product Types
     1.2.2.1. Global Diabetes Devices Market Revenue and Growth Rate Comparison By Product Types (2016-2027)
     1.2.2.2. Global Diabetes Devices Market Revenue Share By Product Types in 2019
     1.2.2.3. Monitoring Devices
       1.2.2.3.1. Self-Monitoring Blood Glucose Device (SMBG)
       1.2.2.3.2. Continuous Blood Glucose Monitoring (CGM)
     1.2.2.4. Treatment Devices
       1.2.2.4.1. Insulin Pens
       1.2.2.4.2. Insulin Pumps
       1.2.2.4.3. Insulin Jet Injectors
       1.2.2.4.4. Insulin Syringes
       1.2.2.4.5. Others
   1.2.3. Diabetes Devices Market By End User
     1.2.3.1. Global Diabetes Devices Market Revenue and Growth Rate Comparison By End User (2016-2027)
       1.2.3.1.1. Diagnostic Centers
       1.2.3.1.2. Hospitals
       1.2.3.1.3. Home Care
       1.2.3.1.4. Ambulatory Surgery Centers
   1.2.4. Diabetes Devices Market By Distribution Channels
     1.2.4.1. Global Diabetes Devices Market Revenue and Growth Rate Comparison By Distribution Channels (2016-2027)
     1.2.4.2. Hospitals Pharmacies
     1.2.4.3. Retail Pharmacies
     1.2.4.4. Diabetes Clinics/Centers
     1.2.4.5. Online Pharmacies
     1.2.4.6. Others
   1.2.5. Diabetes Devices Market By Geography
     1.2.5.1. Global Diabetes Devices Market Revenue and Growth Rate Comparison By Geography (2016-2027)
     1.2.5.2. North America Diabetes Devices Market Revenue and Growth Rate(2016-2027)
     1.2.5.3. Europe Diabetes Devices Market Revenue and Growth Rate(2016-2027)
     1.2.5.4. Asia-Pacific Diabetes Devices Market Revenue and Growth Rate(2016-2027)
     1.2.5.5. Latin America Diabetes Devices Market Revenue and Growth Rate(2016-2027)
     1.2.5.6. Middle East and Africa (MEA)Diabetes Devices Market Revenue and Growth Rate(2016-2027)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Diabetes Devices Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Diabetes Devices Major Manufacturers in 2019
3.3. R&D Status and Technology Source of Global Diabetes Devices Major Manufacturers in 2019
3.4. Raw Materials Sources Analysis of Global Diabetes Devices Major Manufacturers in 2019

CHAPTER 4. DIABETES DEVICES MARKET BY PRODUCT TYPES
4.1. Global Diabetes Devices Revenue By Product Types
4.2. Monitoring Devices
   4.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
   4.2.3. Self-Monitoring Blood Glucose Device (SMBG)
   4.2.4. Continuous Blood Glucose Monitoring (CGM)
4.3. Treatment Devices
   4.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
   4.3.3. Insulin Pens
   4.3.4. Insulin Pumps
   4.3.5. Insulin Jet Injectors
   4.3.6. Insulin Syringes
   4.3.7. Others

CHAPTER 5. DIABETES DEVICES MARKET BY END USER
5.1. Global Diabetes Devices Revenue By End User
5.2. Diagnostic Centers
   5.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.3. Hospitals
   5.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.4. Home Care
   5.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   5.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.5. Ambulatory Surgery Centers
   5.5.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   5.5.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)

CHAPTER 6. DIABETES DEVICES MARKET BY DISTRIBUTION CHANNELS
6.1. Global Diabetes Devices Revenue By Distribution Channels
6.2. Hospitals Pharmacies
   6.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.3. Retail Pharmacies
   6.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.4. Diabetes Clinics/Centers
   6.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   6.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.5. Online Pharmacies
   6.5.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   6.5.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.6. Others
   6.6.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   6.6.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)

CHAPTER 7. NORTH AMERICA DIABETES DEVICES MARKET BY COUNTRY
7.1. North America Diabetes Devices Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.2. North America Diabetes Devices Market Revenue Share Comparison, 2016 & 2027 (%)
7.3. U.S.
   7.3.1. U.S. Diabetes Devices Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   7.3.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   7.3.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)
7.4. Canada
   7.4.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   7.4.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   7.4.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)

CHAPTER 8. EUROPE DIABETES DEVICES MARKET BY COUNTRY
8.1. Europe Diabetes Devices Market Revenue and Growth Rate, 2016 - 2027 ($Million)
8.2. Europe Diabetes Devices Market Revenue Share Comparison, 2016 & 2027 (%)
8.3. UK
   8.3.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   8.3.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   8.3.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)
8.4. Germany
   8.4.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   8.4.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   8.4.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)
8.5. France
   8.5.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   8.5.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   8.5.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)
8.6. Spain
   8.6.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   8.6.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   8.6.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)
8.7. Rest of Europe
   8.7.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   8.7.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   8.7.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)

CHAPTER 9. ASIA-PACIFIC DIABETES DEVICES MARKET BY COUNTRY
9.1. Asia-Pacific Diabetes Devices Market Revenue and Growth Rate, 2016 - 2027 ($Million)
9.2. Asia-Pacific Diabetes Devices Market Revenue Share Comparison, 2016 & 2027 (%)
9.3. China
   9.3.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   9.3.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   9.3.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)
9.4. Japan
   9.4.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   9.4.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   9.4.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)
9.5. India
   9.5.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   9.5.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   9.5.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)
9.6. Australia
   9.6.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   9.6.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   9.6.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)
9.7. South Korea
   9.7.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   9.7.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   9.7.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)
9.8. Rest of Asia-Pacific
   9.8.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   9.8.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   9.8.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)

CHAPTER 10. LATIN AMERICA DIABETES DEVICES MARKET BY COUNTRY
10.1. Latin America Diabetes Devices Market Revenue and Growth Rate, 2016 - 2027 ($Million)
10.2. Latin America Diabetes Devices Market Revenue Share Comparison, 2016 & 2027 (%)
10.3. Brazil
   10.3.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   10.3.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   10.3.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)
10.4. Mexico
   10.4.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   10.4.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   10.4.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)
10.5. Rest of Latin America
   10.5.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   10.5.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   10.5.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA DIABETES DEVICES MARKET BY COUNTRY
11.1. Middle East & AFRICA Diabetes Devices Market Revenue and Growth Rate, 2016 - 2027 ($Million)
11.2. Middle East & AFRICA Diabetes Devices Market Revenue Share Comparison, 2016 & 2027 (%)
11.3. GCC
   11.3.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   11.3.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   11.3.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)
11.4. South Africa
   11.4.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   11.4.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   11.4.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)
11.5. Rest of Middle East & AFRICA
   11.5.1. Market Revenue and Forecast By Product Types, 2016 - 2027 ($Million)
   11.5.2. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
   11.5.3. Market Revenue and Forecast By Distribution Channels, 2016 - 2027 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Abbott Laboratories
   12.1.1. Company Snapshot
   12.1.2. Overview
   12.1.3. Financial Overview
   12.1.4. Type Portfolio
   12.1.5. Key Developments
   12.1.6. Strategies
12.2. Arkray, Inc.
   12.2.1. Company Snapshot
   12.2.2. Overview
   12.2.3. Financial Overview
   12.2.4. Type Portfolio
   12.2.5. Key Developments
   12.2.6. Strategies
12.3. B Braun Melsungen AG
   12.3.1. Company Snapshot
   12.3.2. Overview
   12.3.3. Financial Overview
   12.3.4. Type Portfolio
   12.3.5. Key Developments
   12.3.6. Strategies
12.4. Bayer AG
   12.4.1. Company Snapshot
   12.4.2. Overview
   12.4.3. Financial Overview
   12.4.4. Type Portfolio
   12.4.5. Key Developments
   12.4.6. Strategies
12.5. Lifescan, Inc.
   12.5.1. Company Snapshot
   12.5.2. Overview
   12.5.3. Financial Overview
   12.5.4. Type Portfolio
   12.5.5. Key Developments
   12.5.6. Strategies
12.6. Companion Medical
   12.6.1. Company Snapshot
   12.6.2. Overview
   12.6.3. Financial Overview
   12.6.4. Type Portfolio
   12.6.5. Key Developments
   12.6.6. Strategies
12.7. Dexcom Inc.
   12.7.1. Company Snapshot
   12.7.2. Overview
   12.7.3. Financial Overview
   12.7.4. Type Portfolio
   12.7.5. Key Developments
   12.7.6. Strategies
12.8. F.Hoffmann-La-Ltd.
   12.8.1. Company Snapshot
   12.8.2. Overview
   12.8.3. Financial Overview
   12.8.4. Type Portfolio
   12.8.5. Key Developments
   12.8.6. Strategies
12.9. Insulet Corporation
   12.9.1. Company Snapshot
   12.9.2. Overview
   12.9.3. Financial Overview
   12.9.4. Type Portfolio
   12.9.5. Key Developments
   12.9.6. Strategies
12.10. Lifescan, Inc.
   12.10.1. Company Snapshot
   12.10.2. Overview
   12.10.3. Financial Overview
   12.10.4. Type Portfolio
   12.10.5. Key Developments
   12.10.6. Strategies
12.11. Others
   12.11.1. Company Snapshot
   12.11.2. Overview
   12.11.3. Financial Overview
   12.11.4. Type Portfolio
   12.11.5. Key Developments
   12.11.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
   13.1.1. Initial Data Search
   13.1.2. Secondary Research
   13.1.3. Primary Research
13.2. Assumptions and Scope

Cart Summary